19 May 2013
Keywords: Research productivity, NMEs, In-licenisng, Clinical dropouts, Thomson Reuters
Article | 28 June 2011
The pharmaceutical industry spent less on drug R&D last year than at any time in the last three ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
28 June 2011
17 May 2013
© 2013 thepharmaletter.com